Review



software, version 8.2  (SAS institute)


Bioz Verified Symbol SAS institute is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    SAS institute software, version 8.2
    Software, Version 8.2, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phred+computer+program/software+version+8+2/pmc01895819-64-12-14
    Average 90 stars, based on 1 article reviews
    software, version 8.2 - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Seltoplasmid promotes ulcer healing versus placebo for treating patients with chronic limb-threatening ischemia: HOPE CLTI-2 trial.
    Article Snippet: The HOPE CLTI-2 trial was a phase 3, multicenter, double-blind, placebo-controlled study aimed to evaluate the efficacy and safety of seltoplasmid in patients with Rutherford class 5 CLTI.. This study did not require participants to be ineligible for revascularization, allowing enrollment of patients with CLTI caused by either atherosclerosis (ASO) or Buerger disease (or thromboangiitis obliterans [TAO]).. The primary endpoint was the complete ulcer healing rate at 6 months.

    Article Title: Comparative Hepatic Outcomes of SGLT2i or DPP4i Compared to GLP-1RA in CHB and T2DM Patients.
    Article Snippet: Background: The prevalence of diabetes is increasing among chronic hepatitis B (CHB) patients.. However, the relative efficacy of sodiumglucose cotransporter2 inhibitors (SGLT2i) or dipeptidyl peptidase4 inhibitors (DPP4i), compared with glucagonlike peptide1 receptor agonists (GLP1RA), among such atrisk populations remains unclear in terms of reducing liverrelated events

    Article Title: Exogenous mitochondria added on benefits for cellular prion protein overexpression in adipose-derived mesenchymal stem cells treatment on intracranial hemorrhage rat.
    Article Snippet: SAS statistical software for Windows version 8.2 (SAS Institute, Cary, NC, USA) was used.

    Article Title: Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study.
    Article Snippet: METHODS: We included participants aged 40–79 years receiving a national health checkup from 2009 to 2010 in the Republic of Korea, classified as follows: non-MASLD, MASLD, MASLD with increased alcohol intake (MetALD; weekly alcohol 210–420 g for male and 140–350 g for female individuals), and alcohol-associated liver disease (ALD; excessive alcohol intake with weekly alcohol ‡420 g for male or ‡350 g for female individuals).. The primary outcomewasHCC incidence.. HCC risk was estimated using multivariable Cox proportional hazard models.

    Article Title: Optimal BMI cutoff for lean MASLD/MetALD and adverse hepatic outcomes in East-Asian populations.
    Article Snippet: Nonalcoholic fatty liver disease (NAFLD) is a primary contributor to hepatocellular carcinoma (HCC)/liver cirrhosis (LC), affecting ~30 % of the global population.. Its incidence is rising parallel to increasing prevalences of metabolic syndrome and obesity [1,2].. Although obesity primarily contributes to NAFLD, approximately 3~40 % of NAFLD patients are lean and 20 % in lean population have NAFLD [3].

    Article Title: Robotic-assisted carotid artery stenting with R-One TM : Feasibility and safety assessment in patients with carotid web lesions.
    Article Snippet: Purpose: Robotic-assisted carotid artery stenting (CAS) procedures are on the rise and have demonstrated benefits compared to manual intervention.. The R-OneTM robotic platform has demonstrated safety and efficacy for percutaneous coronary interventions, but its utility for procedures in the common carotid artery has not been thoroughly studied.. This study aims to assess the feasibility and initial safety of the R-OneTM robotic platform for treating patients with carotid artery disease (CAD) presenting with carotid web-diaphragm lesions.

    Article Title: Additional benefits of combined ceftriaxone and adipose-derived mesenchymal stem cells on revamping the outcomes in rodent after acute spinal infection.
    Article Snippet: SAS statistical software for Windows version 8.2 (SAS Institute, adjacent region and inflammatory cell infiltration (i.e., polymorphonuclear cells).

    Software:




    Similar Products

    90
    CodonCode corporation phred computer program
    Phred Computer Program, supplied by CodonCode corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phred+computer+program/phred+program/pm21059791-68-2-8
    Average 90 stars, based on 1 article reviews
    phred computer program - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    CodonCode corporation computer program phred
    Computer Program Phred, supplied by CodonCode corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phred+computer+program/phred+program/pmc02546446-238-6-9
    Average 90 stars, based on 1 article reviews
    computer program phred - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Unigene computer programs phred and cap3
    Computer Programs Phred And Cap3, supplied by Unigene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phred+computer+program/cap3+software/pm16121253-4-12-16
    Average 90 stars, based on 1 article reviews
    computer programs phred and cap3 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results